Can Surrogate Markers Help Define Cardiovascular Disease in Youth?
Preneet Cheema BrarPublished in: Current atherosclerosis reports (2023)
There is no consensus of the ideal method to measure surrogate markers in youth (< 18 years of age), nor standardized imaging protocols for youth. Currently, pediatric normative data are available but not generalizable. In this review, we provide rationale on how currently used surrogates can help identify subclinical atherosclerosis in youth and affirm their role in identifying youth at risk for premature CVD.